Creating and testing innovative methods to improve and accelerate the drug development process and find new treatments for patients faster. Learn more.
-
Research
-
- Funding & Notices
-
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Stem Cell Translation Laboratory
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- A Translational Approach to Addressing COVID-19
- Antiviral Program for Pandemics
- Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
- Multidisciplinary Machine-Assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey
- National COVID Cohort Collaborative (N3C)
- The Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (BGTC)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Functional Genomics Lab
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- Research
- Preclinical Innovation
- Improving the Drug Development Process
Improving the Drug Development Process
NCATS Assay on Top 10 Scientific Achievements List
A scientific society honored NCATS scientists for creating a screening test to identify molecules that block the growth of new blood vessels. The test could be useful in cancer research.
Target Identification & ValidationDeveloping new approaches and technologies to identify and validate potential drug targets in a more efficient and predictable way.
Assay Development & ScreeningEnhancing testing systems to assess the effects of chemical compounds on cellular, molecular or biochemical processes of interest.
Probe Development & Lead OptimizationCreating probes to investigate biological processes and optimizing them to become potential drug candidates.
Core TechnologiesUsing state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.
Target Identification & Validation
Developing new approaches and technologies to identify and validate potential drug targets in a more efficient and predictable way.
Enhancing testing systems to assess the effects of chemical compounds on cellular, molecular or biochemical processes of interest.
Probe Development & Lead Optimization
Creating probes to investigate biological processes and optimizing them to become potential drug candidates.
Using state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.
Work with Us
NCATS pre-clinical programs and resources focus on key obstacles and inefficiencies in the translational process, overcoming bottlenecks that slow the development of new treatments for patients.
Learn more about how to access NCATS programs and expertise.
Learn more about NCATS’ Achievements in Advancing Translational Sciences.
- News & Media
- Funding & Notices
-